The Claim
A digital symptom management platform for gastric cancer survivors is associated with a numerically favorable recovery trajectory in quality of life over six months compared to standard care, with a mean difference of 1.5 points on the KOQUSS-40 scale and a p-value of 0.603 (Cohen’s d = -0.065), indicating no statistically significant difference.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Gastric cancer survivors using a digital symptom management platform showed a small, non-significant improvement in quality of life over six months compared to those receiving standard care.
See the scientific wording
A digital symptom management platform for gastric cancer survivors shows a numerically favorable recovery trajectory in quality of life over six months, though the difference from standard care is not statistically significant (mean difference 1.5 points on KOQUSS-40, p=0.603, Cohen’s d=-0.065), indicating a potential signal requiring larger trials.
Tracking symptoms daily helps a person notice patterns in how their body feels, which leads to more consistent use of breathing or relaxation techniques. This lowers stress hormone levels, reduces inflammation, and improves how the body recovers after cancer treatment.
What the research says
1 studyPeople using the digital tool felt a little better during recovery than those who didn’t, but the difference wasn’t big enough to be certain it wasn’t just luck. Still, most users liked the tool and felt more in control, so it’s worth testing on more people.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.